Interstitial lung disease (ILD) is a broad category of lung diseases that includes more than 130 disorders. Common characteristics of ILD are scarring (pulmonary fibrosis) and/or inflammation of the lungs.
As the leading respiratory hospital in the nation, National Jewish Health in Denver, Colorado, has vast experience in treating people with these rare and complex conditions. Our multidisciplinary team is dedicated to helping people with ILD and to developing new treatments to give you a better life.
National Jewish Health is a Specialized Center of Research for ILD, as designated by the National Institutes of Health. We work together to understand the causes of ILD and to develop new treatments. This ensures that you have access to the latest ILD clinical trials and most effective therapies.
Interstitial Lung Disease Care at National Jewish Health
At National Jewish Health, you’ll find:
- The latest clinical trials
- A focused and integrated approach
- State-of-the-art pulmonary testing and treatments
- Comprehensive pulmonary rehabilitation services
- Familial Pulmonary Fibrosis Genetic Counseling Program
- Support groups.
Our team of doctors, nurses, respiratory therapists, lab technicians and clinical research coordinators will create a detailed plan of diagnosis and care for you, based on the latest information available regarding ILD.
Learn more about the Interstitial Lung Disease Program.